foxo4-dri cancer senolytic human trial FOXO4-DRI: Status, Research & Data Peptide inhibitors targeting FOXO4-p53 interactions – foxo4-dri senolytic peptide animal study – Dose:10/10mg BPC-157 – 5 mg clinically tested
SKU: 80392521552
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12




















